AGPAT4-IN-1
AGPAT4-IN-1 (Compound CL26) is a covalent AGPAT4 inhibitor with an IC50 of 795 nM. AGPAT4-IN-1 covalently binds to AGPAT4 at Cys228 and significantly inhibits acyltransferase activity, LPA-to-PA conversion and downstream mTOR/S6K pathways. AGPAT4-IN-1 sensitizes hepatocellular carcinoma (HCC) tumors to Sorafenib (HY-10201) and significantly induces apoptosis with a synergistic response. AGPAT4-IN-1 has antitumor activity and reduces tumorigenicity and stemness in HCC xenograft mouse models[1].
Product Specifications
UNSPSC
12352100
Target
Acyltransferase; Apoptosis; mTOR; Ribosomal S6 Kinase (RSK)
Related Pathways
Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
O=C(CCl)NCC(O1)=CC=C1C(S2)=NC3=C2C=CC=C3
Molecular Formula
C14H11ClN2O2S
Molecular Weight
306.77
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-175646/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2411250-59-2]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
POU2F2 Antibody - N-terminal region : FITC (ARP34383_T100-FITC)
